Swiss Re AG
OTC:SSREF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
OTC:SSREF
|
CH |
|
A
|
Aegean Airlines SA
F:32A
|
GR |
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
Dai Nippon Printing Co Ltd
F:DNP0
|
JP |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
P
|
Pebble Beach Systems Group PLC
F:VSF
|
UK |
Wall St Price Targets
SSREF Price Targets Summary
Swiss Re AG
According to Wall Street analysts, the average 1-year price target for SSREF is 164.19 USD with a low forecast of 142.93 USD and a high forecast of 212.27 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SSREF's stock price target?
Price Target
164.19
USD
According to Wall Street analysts, the average 1-year price target for SSREF is 164.19 USD with a low forecast of 142.93 USD and a high forecast of 212.27 USD.
What is the Revenue forecast for Swiss Re AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Swiss Re AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 6%.
